These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 22116627)
1. Association of NQO1 Pro187Ser polymorphism with the risks for colorectal cancer and colorectal adenoma: a meta-analysis. Zhou JY; Shi R; Yu HL; Zheng WL; Ma WL Int J Colorectal Dis; 2012 Aug; 27(8):1123-4. PubMed ID: 22116627 [No Abstract] [Full Text] [Related]
2. Contribution of NAD(P)H quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and risk of colorectal adenoma and colorectal cancer in Caucasians: a meta-analysis. Chen J; Lin Y; Zhang R; Huang ZJ; Pan XG Arch Med Res; 2012 Jan; 43(1):58-66. PubMed ID: 22306249 [TBL] [Abstract][Full Text] [Related]
3. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis. Chao C; Zhang ZF; Berthiller J; Boffetta P; Hashibe M Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):979-87. PubMed ID: 16702380 [TBL] [Abstract][Full Text] [Related]
4. CYP1A1 Val462 and NQO1 Ser187 polymorphisms, cigarette use, and risk for colorectal adenoma. Hou L; Chatterjee N; Huang WY; Baccarelli A; Yadavalli S; Yeager M; Bresalier RS; Chanock SJ; Caporaso NE; Ji BT; Weissfeld JL; Hayes RB Carcinogenesis; 2005 Jun; 26(6):1122-8. PubMed ID: 15731166 [TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of the association between NQO1 Pro187Ser polymorphism and colorectal cancer in Asians. Zhao H; Zhu F; Sun J; Meng X Tumour Biol; 2014 Mar; 35(3):2111-6. PubMed ID: 24142528 [TBL] [Abstract][Full Text] [Related]
6. Letter to the editor: a meta-analyses of association between polymorphism of MTHFR A1298C and colorectal cancer risk. Ge H; Zheng X; Zhao E; Sheng X; Lu S; Cheng S; Yu J Int J Colorectal Dis; 2012 Oct; 27(10):1387-8. PubMed ID: 22350268 [No Abstract] [Full Text] [Related]
7. Evidence on the association between NQO1 Pro187Ser polymorphism and breast cancer risk in the current studies: a meta-analysis. Yuan W; Xu L; Chen W; Wang L; Fu Z; Pang D; Li D Breast Cancer Res Treat; 2011 Jan; 125(2):467-72. PubMed ID: 20526805 [TBL] [Abstract][Full Text] [Related]
8. Role of MTHFR C677T polymorphism in systemic carcinogenesis, besides its role in the pathogenesis of colo-rectal carcinomas. Kapoor S Genet Mol Res; 2012 Sep; 11(3):3365-6. PubMed ID: 23079830 [No Abstract] [Full Text] [Related]
9. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population. Sameer AS; Shah ZA; Syeed N; Rasool R; Afroze D; Siddiqi MA Asian Pac J Cancer Prev; 2010; 11(1):209-13. PubMed ID: 20593958 [TBL] [Abstract][Full Text] [Related]
10. NAD(P)H:quinone oxidoreductase 1 Pro187Ser polymorphism and expression do not cosegregate with clinico-pathological characteristics of human mammary tumors. Hubackova M; Vaclavikova R; Mrhalova M; Kubackova K; Kodet R; Gut I; Soucek P Pharmacogenet Genomics; 2009 Jul; 19(7):505-12. PubMed ID: 19494791 [TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of the association between the XRCC1 gene R399Q polymorphism and colorectal cancer: an update. Wu W; Wu Y; Wang M; Zhang D Int J Colorectal Dis; 2013 Oct; 28(10):1453-4. PubMed ID: 23233244 [No Abstract] [Full Text] [Related]
12. NQO1 and mEH exon 4 (mEH4) gene polymorphisms, smoking and colorectal cancer risk. Mitrou P; Watson M; Bingham S; Stebbings WS; Speakman CT; Loktionov A IARC Sci Publ; 2002; 156():495-7. PubMed ID: 12484241 [No Abstract] [Full Text] [Related]
13. Association of NQO1 rs1800566 polymorphism and the risk of colorectal cancer: a meta-analysis. Ding R; Lin S; Chen D Int J Colorectal Dis; 2012 Jul; 27(7):885-92. PubMed ID: 22215148 [TBL] [Abstract][Full Text] [Related]
14. Association between NQO1 Pro187Ser polymorphism and esophageal cancer: a meta-analysis. Liu K; Tian H; Yu KZ; Shen WY; Mao ZC; Jin CH; Pan HB; He JX Tumour Biol; 2014 Mar; 35(3):2063-8. PubMed ID: 24213850 [TBL] [Abstract][Full Text] [Related]
15. Correlative polymorphism of NAD(P)H: quinone oxidoreductase (NQO1) with telomere shortening in colorectal cancer. Takagi S; Kinouchi Y; Hiwatashi N; Hirai M; Suzuki S; Takahashi S; Negoro K; Obana N; Shimosegawa T Anticancer Res; 2002; 22(5):2749-52. PubMed ID: 12529991 [TBL] [Abstract][Full Text] [Related]
16. Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer. van der Logt EM; Bergevoet SM; Roelofs HM; Te Morsche RH; Dijk Yv; Wobbes T; Nagengast FM; Peters WH Mutat Res; 2006 Jan; 593(1-2):39-49. PubMed ID: 16039674 [TBL] [Abstract][Full Text] [Related]
17. Association analysis of NAD(P)H:quinone oxidoreductase gene 609 C/T polymorphism with Alzheimer's disease. Wang B; Jin F; Xie Y; Tang Y; Kan R; Zheng C; Yang Z; Wang L Neurosci Lett; 2006 Dec; 409(3):179-81. PubMed ID: 17027152 [TBL] [Abstract][Full Text] [Related]
18. Association of bladder cancer risk with an NAD(P)H:quinone oxidoreductase polymorphism in an ethnic Kashmiri population. Pandith AA; Khan NP; Shah ZA; Shah AM; Wani SM; Siddiqi MA Biochem Genet; 2011 Aug; 49(7-8):417-26. PubMed ID: 21253823 [TBL] [Abstract][Full Text] [Related]
19. The influence of fruit and vegetable consumption and genetic variation on NAD(P)H:quinone oxidoreductase (NQO1) phenotype in an endoscopy-based population. Tijhuis MJ; Boerboom AM; Visker MH; Op den Camp L; Nagengast FM; Tan AC; Rietjens IM; Kok FJ; Aarts JM; Kampman E Nutr Cancer; 2008; 60(2):204-15. PubMed ID: 18444152 [TBL] [Abstract][Full Text] [Related]
20. Low-penetrance genes and their involvement in colorectal cancer susceptibility. de Jong MM; Nolte IM; te Meerman GJ; van der Graaf WT; de Vries EG; Sijmons RH; Hofstra RM; Kleibeuker JH Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1332-52. PubMed ID: 12433710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]